Wang, X., Tian, H., Chi, Z., Lu, S., Sheng, X., Hu, H., . . . Cui, C. (Feb 2025). Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: Phase Ia/Ib trial results and biomarker insights. Journal for Immunotherapy of Cancer. https://doi.org/10.1136/jitc-2024-010662
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Wang, Xuan, et al. "Oncolytic Virus OH2 Extends Survival in Patients with PD-1 Pretreated Melanoma: Phase Ia/Ib Trial Results and Biomarker Insights."
Journal for Immunotherapy of Cancer Feb 2025. https://doi.org/10.1136/jitc-2024-010662.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Wang, Xuan, et al. "Oncolytic Virus OH2 Extends Survival in Patients with PD-1 Pretreated Melanoma: Phase Ia/Ib Trial Results and Biomarker Insights."
Journal for Immunotherapy of Cancer, Feb 2025, https://doi.org/10.1136/jitc-2024-010662.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.